Institute of Neurology, University College London, London WC1N 3BG, United Kingdom.
Annu Rev Med. 2012;63:259-76. doi: 10.1146/annurev-med-081210-101714.
Since the landmark NASCET and ECST trials demonstrated the superiority of carotid endarterectomy over medical therapy in the prevention of stroke for patients with symptomatic carotid artery stenosis, surgical intervention as a part of secondary prevention of stroke has become widespread. However, the newer technology of carotid artery angioplasty and stenting challenges this mode of intervention, promising the benefits of a procedure under local anesthesia and potentially avoiding the surgical complications of cranial nerve palsy and hematoma. Pooled evidence from randomized controlled trials of endarterectomy versus stenting shows a higher rate of stroke or death in the stenting groups-but this finding is mitigated to an extent by the lower incidence of myocardial infarction and cranial nerve palsy in patients undergoing stenting. At present, carotid endarterectomy combined with optimal drug therapy remains the standard of care for symptomatic 70%-99% stenosis of the internal carotid artery, but stenting might be an option in younger patients and in those not suitable for endarterectomy.
自 NASCET 和 ECST 试验以来,这些里程碑式的研究表明,在预防症状性颈动脉狭窄患者的中风方面,颈动脉内膜切除术优于药物治疗,因此,手术干预作为中风二级预防的一部分已经广泛开展。然而,颈动脉血管成形术和支架置入术等新技术对这种干预模式提出了挑战,它承诺了在局部麻醉下进行手术的好处,并有可能避免颅神经麻痹和血肿等手术并发症。来自颈动脉内膜切除术与支架置入术的随机对照试验的汇总证据表明,支架置入组的中风或死亡率更高,但这一发现因支架置入患者心肌梗死和颅神经麻痹发生率较低而在一定程度上得到缓解。目前,颈动脉内膜切除术联合最佳药物治疗仍然是治疗症状性 70%-99%颈内动脉狭窄的标准方法,但在年轻患者和不适合内膜切除术的患者中,支架置入术可能是一种选择。